Mon Jan 06 15:54:43 UTC 2025: ## India Monitors Human Metapneumovirus (HMPV) Cases Amidst China Concerns; Experts Downplay Pandemic Threat

**NEW DELHI** – India has reported cases of Human Metapneumovirus (HMPV), a respiratory virus that has gained attention following a rise in cases in China. While causing cold-like symptoms to severe pneumonia in vulnerable groups, experts emphasize that HMPV is not a new virus and is unlikely to cause a pandemic like COVID-19.

HMPV, discovered in 2001, affects the upper and lower respiratory tract, causing symptoms similar to COVID-19, including fever, cough, and shortness of breath. It primarily affects children, the elderly, and those with weakened immune systems. Although sharing similarities with SARS-CoV-2 in transmission and symptoms, HMPV spreads more slowly and lacks the high death rate associated with severe COVID-19. Crucially, unlike COVID-19, there are no widely available vaccines or antiviral treatments for HMPV.

Several leading pulmonologists and healthcare officials have downplayed the threat of an HMPV pandemic. They highlight that most individuals are exposed to HMPV early in life, leading to partial immunity and reducing the severity of subsequent infections. The recent increase in cases in China is attributed to seasonal patterns and increased testing rather than a novel outbreak. Moreover, the Indian government reports no significant increase in influenza-like illnesses.

While acknowledging the need for continued monitoring, experts emphasize that standard preventive measures—hand hygiene, mask-wearing, and social distancing—remain effective against HMPV. They stress that the virus poses a greater risk to individuals with compromised immune systems. The National Centre for Disease Control (NCDC) has also stated there is no cause for alarm and that healthcare systems are adequately prepared for seasonal surges in respiratory illnesses. Global health authorities continue to monitor the situation, but currently, there is no indication of a global pandemic threat from HMPV.

Read More